Isolation of a tumor factor responsible for angiogenesis

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Solid tumors require new blood vessel formation (angiogenesis) to grow beyond a minimal size.
• Tumor-angiogenesis factor (TAF) is released by both human and animal solid tumors.
• TAF acts as a mitogen for capillary endothelial cells, promoting blood vessel growth.

Purpose of the Study:

• To investigate the nature and role of tumor-angiogenesis factor (TAF) in solid tumor development.
• To explore the potential of targeting TAF for cancer therapy.

Main Methods:

• The study identifies a factor elaborated by solid tumors that stimulates capillary endothelial cells.
• The key components of this factor, TAF, are identified as RNA and protein.

Main Results:

• A factor mitogenic to capillary endothelial cells, termed tumor-angiogenesis factor (TAF), is produced by solid tumors.
• TAF is composed of RNA and protein components.
• The findings suggest that TAF plays a crucial role in tumor angiogenesis.

Conclusions:

• Blockade or inhibition of tumor-angiogenesis factor (TAF) is proposed as a strategy to arrest solid tumor growth.
• Inhibiting angiogenesis by targeting TAF could limit solid tumors to a diameter of a few millimeters.